### Dangerous Contradictions

- **Testing Resource Allocation Conflict**
  - **runtime-safety claims**: "Require live integration tests (marked `@pytest.mark.live`) for all provider contract implementations" (recommendation #7, L79-83) with Priority P3.
  - **packaging-distribution claims**: "Distribution paths MUST have end-to-end test coverage. Install tests MUST verify packaged functionality in clean environments" (recommendation #3, L49-53) with Priority P1.
  - **Why this is dangerous**: Both require significant CI infrastructure investment but target different failure modes. Live provider tests consume API credits and require external service dependencies, while distribution tests require isolated environments and multiple installation paths. Implementing both simultaneously could overwhelm CI resources and create competing maintenance burdens.
  - **Suggested resolution**: Implement distribution testing first (P1 priority is justified - broken installations affect all users), then add live provider testing as CI capacity allows. Consider using different CI triggers (distribution tests on all PRs, live provider tests on releases only).

- **Constitutional Scope Competition**
  - **runtime-safety claims**: Multiple P1 recommendations for provider contracts, synthesis auditing, and defense-in-depth patterns (recommendations #1-3, L43-59).
  - **packaging-distribution claims**: Multiple P1 recommendations for distribution integrity, versioning, and build-time validation (recommendations #1-3, L37-53).
  - **Why this is dangerous**: Adding 6+ new constitutional principles simultaneously risks principle bloat and reduces the Constitution's clarity. Each domain wants comprehensive coverage, but the Constitution works best when focused on essential invariants.
  - **Suggested resolution**: Prioritize based on user impact and bug frequency. Distribution failures break installations immediately (high user visibility), while provider failures affect deliberation quality (high operational impact). Consider phased constitutional updates rather than a single large expansion.

- **Error Handling Philosophy Divergence**
  - **runtime-safety claims**: "synthesis verdicts in safety-critical modes (red-blue, gate checks) MUST use schema-level required fields, parser-level validation, and contract tests" (recommendation #1, L43-47).
  - **packaging-distribution claims**: "Distribution artifacts MUST be tested in isolation from development environments" and "Wheel contents MUST be validated against expected manifests" (recommendation #3, L49-53).
  - **Why this is dangerous**: Both demand rigorous validation but at different system layers (runtime synthesis vs build-time packaging). Implementing both creates duplicate validation overhead and unclear failure responsibility - when a distribution test fails due to a synthesis validation error, which team owns the fix?
  - **Suggested resolution**: Establish validation layer ownership: packaging owns distribution surface correctness, runtime-safety owns deliberation correctness. Synthesis validation should not block packaging, packaging validation should not duplicate synthesis checks.

### Tensions

- **Testing Philosophy Alignment**
  - **runtime-safety's position**: Emphasizes provider contract validation through live integration tests that "exercise real subprocess behavior that unit tests miss" (L82).
  - **packaging-distribution's position**: Emphasizes distribution validation through "install tests [that] verify packaged functionality in clean environments" (L51-52).
  - **Nature of tension**: Both approaches require infrastructure investment and add complexity, but they validate different system boundaries. Live tests validate external dependencies, distribution tests validate internal packaging correctness. Both are necessary but compete for development effort.
  - **Coordination needed**: Establish clear ownership boundaries - runtime team owns provider integration testing, packaging team owns distribution testing. Share CI infrastructure patterns to avoid duplicate tooling.

- **Single Source of Truth Application**
  - **runtime-safety's position**: Focuses on provider contract standardization: "all providers to implement: token consumption reporting, rate limit handling with exponential backoff" (L50-51).
  - **packaging-distribution's position**: Focuses on version authority: "Version information MUST be single-sourced from `pyproject.toml` `[project] version`" (L45).
  - **Nature of tension**: Both invoke Principle XI (Single Source of Truth) but apply it to different domains. Runtime wants contract standardization, packaging wants version centralization. Both are valid applications but could create confusion about what "single source" means.
  - **Coordination needed**: Clarify that Principle XI applies to information duplication, not implementation standardization. Version authority belongs in packaging domain, contract specifications belong in runtime domain.

- **Validation Layering Strategy**
  - **runtime-safety's position**: Advocates for "schema → parser → contract test defense layers" as a mandatory pattern for safety-critical components (L55-59).
  - **packaging-distribution's position**: Advocates for "Build-time artifact projection MUST be deterministic and auditable" with explicit force-include declarations (L73-77).
  - **Nature of tension**: Both want layered validation but at different lifecycle stages (runtime synthesis vs build-time artifact generation). The patterns are complementary but could create validation complexity if not coordinated.
  - **Coordination needed**: Ensure validation layers complement rather than duplicate. Runtime validation should not re-validate what packaging already guarantees, packaging validation should not block on runtime concerns.

- **Priority Balancing Between Domains**
  - **runtime-safety's position**: Three P1 recommendations focusing on synthesis auditing, provider contracts, and defense-in-depth (L43-59).
  - **packaging-distribution's position**: Three P1 recommendations focusing on distribution integrity, versioning, and installation testing (L37-53).
  - **Nature of tension**: Both domains identify critical gaps but assign highest priority to their respective concerns. True priority should reflect user impact and bug frequency across both domains.
  - **Coordination needed**: Cross-domain impact assessment to determine which P1 items genuinely require immediate constitutional coverage vs which can be addressed through implementation standards first.

- **Infrastructure Investment Competition**
  - **runtime-safety's position**: Requires significant provider testing infrastructure including live API calls and subprocess management (recommendations #7-8).
  - **packaging-distribution's position**: Requires significant packaging validation infrastructure including isolated environments and multi-channel testing (recommendations #3-5).
  - **Nature of tension**: Both domains need substantial CI/CD investment but for different validation targets. Limited development resources create natural competition between runtime vs packaging infrastructure priorities.
  - **Coordination needed**: Stagger infrastructure investments based on bug impact data. Coordinate tooling choices to maximize reuse between validation domains.

### Safe Agreements

- **Schema-Driven Validation Convergence**
  - **Shared position**: runtime-safety advocates "schema-level required fields, parser-level validation" (L44-45), packaging-distribution advocates "Build-time artifact projection MUST be deterministic and auditable" with schema validation (L75).
  - **Combined evidence**: Both reviews identify that ad-hoc validation patterns create bugs (PR #10's false-PASS for runtime, PR #11's missing wheel contents for packaging). Schema-driven validation provides verifiable contracts that prevent silent failures in both domains.
  - **Confidence level**: High. Schema validation is a proven pattern that both domains can implement independently without interference.

- **End-to-End Testing Necessity**
  - **Shared position**: runtime-safety wants "live integration tests for real subprocess exercise" (L81-82), packaging-distribution wants "Distribution paths MUST have end-to-end test coverage" (L50).
  - **Combined evidence**: Both domains have experienced bugs that unit tests missed (provider protocol changes in runtime, packaging configuration errors in distribution). End-to-end testing validates integration points that unit tests cannot cover.
  - **Confidence level**: High. Both domains provide concrete examples of integration bugs that only end-to-end testing would catch.

- **Ad-Hoc Practice Formalization**
  - **Shared position**: runtime-safety notes "recent changes #5, #6, #8, #9, and especially #10 demonstrate ad-hoc fixes for runtime safety issues that constitutional principles should have caught" (L3), packaging-distribution notes "Recent PRs (#11, #13, #14) reveal a pattern of distribution-surface failures that could have been prevented with constitutional packaging discipline" (L3).
  - **Combined evidence**: Both reviews provide extensive documentation of recent PRs that fixed problems through implementation changes rather than preventing them through constitutional guidance. This pattern indicates missing architectural principles.
  - **Confidence level**: High. The evidence from recent changes strongly supports the need for constitutional updates in both domains.

- **Explicit Contract Requirements**
  - **Shared position**: runtime-safety advocates "explicit constitutional contracts, not just implementation-level handling" (L53), packaging-distribution advocates "Package boundaries MUST be explicit" and explicit force-include declarations (L69-70).
  - **Combined evidence**: Both domains show that implicit assumptions fail (provider homogeneity assumption failed for runtime, implicit distribution correctness failed for packaging). Explicit contracts prevent assumption-based failures.
  - **Confidence level**: Medium. While both domains agree on explicitness, the implementation approaches differ significantly and would require careful coordination to avoid conflicts.